デフォルト表紙
市場調査レポート
商品コード
1625018

精子バンク市場:サービス別、ドナー別、地域別、範囲および予測

Sperm Bank Market By Services (Sperm Storage, Genetic Consultation), By Donor (Known Donor, Anonymous Donor)By Geographic Scope And Forecast


出版日
ページ情報
英文 202 Pages
納期
2~3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
精子バンク市場:サービス別、ドナー別、地域別、範囲および予測
出版日: 2024年10月07日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

精子バンク市場の評価、2024年~2031年

世界の精子バンク市場は成長を続けると予測されます。この成長はいくつかの要因に起因するが、その1つは男女ともに不妊症の有病率が上昇していることです。2023年の市場規模は47億4,680万米ドルで、2031年には76億8,642万米ドルに拡大し、2024年から2031年までのCAGRは6.21%で成長すると予測されます。精子提供や人工授精の代替法に関する人々の意識が高まっています。精子凍結保存技術の進歩も一因です。これらの技術により、生存率を損なうことなく精子を長期間保存できるようになった。精子バンクサービス市場はまた、新規参入業者の参入によりコスト低下が起こっています。最後に、法律や社会の変化により、同性カップルや独身女性が子供を妊娠することがより簡単になってきています。

精子バンク市場定義/概要

精子バンクは、精液バンクやクライオバンクと呼ばれることもあり、精子細胞を収集、凍結、保存するための施設です。精子細胞は、厳格なスクリーニング・プロセスを経たボランティア・ドナーから提供されます。

男性不妊症に関する社会的啓蒙活動の増加は、精子提供率の増加につながるのでしょうか?

男性不妊症に関する啓蒙キャンペーンは、精子提供率の上昇につながるという仮説があります。一方では、このようなキャンペーンは男性不妊の有病率や原因について男性を教育する可能性があります。これにより、男性不妊症にまつわるスティグマを払拭し、他の人が親になることを支援する手段として精子提供を検討するよう男性に促すことができます。精子提供を正常化し、そのプロセスや潜在的な健康リスクに関する誤解に対処することで、啓発キャンペーンは、より多くの情報提供者を惹きつけることができます。

一方、このようなキャンペーンの効果は、特定の社会的・文化的障壁によって制限されるかもしれないです。文化や宗教によっては、精子提供に対して抵抗感を抱いている場合があり、認知度が高まっているにもかかわらず、潜在的なドナーの抑止力となっています。さらに、精子バンクが提供する金銭的報酬のレベルや提供される匿名性の程度は、ドナーのモチベーションに影響を与える可能性があります。また、ドナーの審査が厳しいと、たとえ一般への認知度が高まったとしても、対象となる男性の数が制限される可能性があります。結論として、一般の認識向上キャンペーンは精子提供率の向上に貢献しうるが、他の戦略と組み合わせることでその効果は増幅される可能性が高いです。これには、提供プロセスの合理化、不妊に悩む家族へのポジティブな影響の強調、特定の層にアプローチするための擁護団体との提携などが考えられます。啓発キャンペーンと精子提供率との因果関係を明確にするには、さらなる調査が必要であろう。

精子提供の商業化が進み、営利目的の精子バンクが台頭することで、市場に法的・社会的な影響が生じることはないのでしょうか?

精子提供の商業化の進展と営利精子バンクの台頭は、市場に法的・社会的影響の連鎖をもたらすと予測されます。これらの影響は、慎重な検討を必要とする懸念を引き起こします。

法的には、商業化によって親権と義務の境界線が曖昧になる可能性があります。ドナー、レシピエント、子孫の間で、特に接触や経済的支援の問題に関して紛争が生じる可能性があります。現行の法的枠組みは、こうした新たな複雑性に対処するために改正が必要かもしれないです。さらに、特に金銭的報酬が主な動機となる場合、精子ドナーの潜在的搾取に関する懸念も存在します。倫理的違反を避けるためには、インフォームド・コンセントを確実にし、ドナーの権利を保護することが最も重要になります。さらに、商業化が進むと、特定のドナーの特徴が優先される市場主導型のアプローチになる可能性があり、人種や民族、その他の要因による差別につながる可能性があります。そのような行為を防ぐために、規制を強化する必要があるかもしれないです。社会的には、精子提供が商業化されることで、子育ての商品化に対する懸念が生じる可能性があります。不妊治療は、経済的に余裕のない人々にとってはますます手の届かないものになるかもしれないです。営利を目的とした精子バンクの台頭は、生物学的起源に関する情報を求めるドナーの子孫の匿名性や離人感を助長するかもしれないです。このような懸念に対処するためには、支援体制や倫理的ガイドラインが必要かもしれないです。最後に、精子提供の商業化は、親としてのあり方、家族形成、そしてすべての関係者の権利をめぐる倫理的議論を再燃させる。

精子提供の商業化は、複雑な状況を提示しています。責任ある公平な精子バンク市場を確保するためには、しっかりとした規制、倫理的ガイドライン、そして開かれた議論を通じて、法的および社会的な影響に対処することが不可欠です。

目次

第1章 世界の精子バンク市場のイントロダクション

  • 市場のイントロダクション
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界の精子バンク市場の展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 世界の精子バンク市場:サービス別

  • 概要
  • 精子保管
  • 遺伝相談
  • 精液分析

第5章 世界の精子バンク市場:ドナー別

  • 概要
  • 既知のドナー
  • 匿名ドナー

第7章 精子バンクの世界市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第8章 世界の精子バンク市場の競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な発展戦略

第9章 企業プロファイル

  • California Cryobank
  • Fairfax Cryobank, Inc.
  • Androcryos
  • Cryos International ApS
  • Cryos International ApS
  • CRYOBANK GROUP, INC
  • Indian Spertech
  • European Sperm Bank
  • ReproTech LLC
  • XYTEX
  • New England Cryogenic Center

第9章 主な発展

  • 製品上市/開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第10章 付録

  • 関連調査
目次
Product Code: 25863

Sperm Bank Market Valuation - 2024-2031

The global Sperm Bank Market is projected to continue growth. This growth is attributed to several factors, one of which is the rising prevalence of infertility among both men and women. The market was valued at USD 4746.8 Million in 2023 and is expected to expand to USD 7686.42 Million in 2031 , growing at a CAGR of 6.21% from 2024 to 2031. Public awareness is increasing regarding sperm donation and alternative insemination methods. Advancements in sperm cryopreservation techniques are another contributing factor. These techniques permit sperm to be stored for extended periods without compromising viability. The sperm banking service market is also experiencing a cost decline due to the entry of new players. Finally, legal and social changes are making it more straightforward for same-sex couples and single women to conceive children.

Sperm Bank Market: Definition/ Overview

A sperm bank, also sometimes called a semen bank or cryobank, is a facility designed to collect, freeze, and store sperm cells. Sperm cells can come from volunteer donors who undergo a rigorous screening process.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Can an increase in public awareness campaigns regarding male infertility lead to a rise in sperm donation rates?

Public awareness campaigns regarding male infertility are hypothesized to lead to an increase in sperm donation rates. On the one hand, such campaigns have the potential to educate men about the prevalence and causes of male infertility. This could dispel the stigma surrounding the condition and encourage men to consider sperm donation as a means of assisting others in achieving parenthood. By normalizing sperm donation and addressing misconceptions about the process or potential health risks, awareness campaigns could attract a larger pool of informed donors.

On the other hand, the effectiveness of these campaigns might be limited by certain social and cultural barriers. Some cultures or religions may hold reservations about sperm donation, acting as a deterrent to potential donors despite increased awareness. Additionally, the level of financial compensation offered by sperm banks and the degree of anonymity provided can influence donor motivation. Stringent donor screening processes might also restrict the number of eligible men, even with heightened public awareness. In conclusion, while public awareness campaigns can contribute to increased sperm donation rates, their effectiveness is likely amplified when combined with other strategies. These could include streamlining the donation process, highlighting the positive impact on families struggling with infertility, and partnering with advocacy groups to reach specific demographics. Further research would be necessary to definitively establish the causal relationship between awareness campaigns and sperm donation rates.

Will the increasing commercialization of sperm donation and the rise of for-profit sperm banks cause legal and social implications for the market?

The increasing commercialization of sperm donation and the dominance of for-profit sperm banks are predicted to lead to a cascade of legal and social implications for the market. These implications raise concerns that require careful consideration.

Legally, commercialization could blur the lines of parentage and obligation. Disputes between donors, recipients, and offspring may arise, particularly regarding issues of contact or financial support. Current legal frameworks might need revision to address these new complexities. Additionally, concerns exist around the potential exploitation of sperm donors, especially if financial compensation becomes the primary motivator. Ensuring informed consent and protecting donor rights becomes paramount to avoid ethical violations. Furthermore, commercialization could lead to a market-driven approach where certain donor traits are prioritized, potentially leading to discrimination based on race, ethnicity, or other factors. Regulations might need to be strengthened to prevent such practices. Socially, the commercialization of sperm donation could raise concerns about the commodification of parenthood. Fertility treatments might become increasingly inaccessible for those with limited financial means. The rise of for-profit sperm banks might contribute to a sense of anonymity or detachment for donor offspring seeking information about their biological origins. Support structures and ethical guidelines might be needed to address these concerns. Finally, the commercialization of sperm donation reignites ethical debates surrounding the nature of parenthood, family formation, and the rights of all parties involved.

The commercialization of sperm donation presents a complex landscape. To ensure a responsible and equitable Sperm Bank Market, it is imperative to address the legal and social implications through robust regulations, ethical guidelines, and open discussions.

Category-Wise Acumens

What are the Drivers Encouraging Sperm Storage Services in the Market?

The sperm storage segment is estimated to dominate the market during the forecast period. Medical developments and societal changes have resulted in an increase in couples and people seeking assisted reproductive technologies such as in vitro fertilization (IVF) and intrauterine insemination (IUI). Sperm storage is critical in these operations because it allows people to keep their fertility or use donated sperm to conceive.

Delaying parenting, medical treatments that can affect fertility (e.g., cancer therapy), and the desire to have a biological child later in life are all driving up demand for sperm preservation. This permits people to save their reproductive potential for later use.

More people and couples are turning to donated sperm to get pregnant. Sperm banks offer a safe and controlled source of sperm, as well as thorough information about donors, which increases recipients' comfort. Sperm preservation is the foundation for these donor sperm services.

Country/Region-wise Acumens

Can rising healthcare costs in North America create a barrier to entry for some individuals or couples seeking fertility treatments that utilize sperm banks?

Rising healthcare costs in North America are predicted to create a barrier to entry for some individuals and couples seeking fertility treatments that utilize sperm banks. This financial strain stems from several factors. Sperm bank services themselves incur fees. These include storage costs, donor selection expenses, and potential genetic consultations. While sperm bank services are just one component of the overall financial picture for fertility treatments like IUI or IVF, their rising costs can make it difficult for some to afford the combined expenses, particularly when healthcare costs, in general, are also on the rise.

Insurance coverage for fertility treatments varies considerably across North American healthcare plans. Limited or absent coverage for sperm bank services or fertility treatments can leave individuals and couples with the full financial burden. This can force them into difficult choices, potentially prioritizing essential medical needs over fertility treatments or delaying family planning altogether. However, there are potential mitigating factors to consider. Some sperm banks and fertility clinics might offer financing options to help spread out the cost of services, making them more accessible to a wider range of income levels. Additionally, rising healthcare costs in North America could lead to an increase in fertility tourism, where individuals travel to other countries with lower treatment costs. While this option presents potential benefits, concerns about quality standards and legal complications remain.

Ongoing discussions about healthcare access and advocacy efforts could lead to increased insurance coverage for fertility treatments and sperm bank services. This would make these options more financially accessible and alleviate the burden on individuals and couples seeking to build families through sperm donation and assisted reproductive technologies.

How will evolving social attitudes towards infertility and alternative family planning methods impact the demand for sperm bank services in specific Asia Pacific countries with strong cultural traditions?

The evolving social attitudes towards infertility and alternative family planning methods in Asia Pacific countries with strong cultural traditions are expected to have a complex and multifaceted impact on the demand for sperm bank services. On the one hand, a decrease in stigma surrounding infertility could lead to a rise in demand for sperm banks. As societal views become more accepting, individuals and couples struggling to conceive might feel less pressure to conform to traditional family planning methods. This could encourage them to consider sperm banks as a viable option for building a family.

Furthermore, evolving gender roles and a growing emphasis on women's empowerment might create a more open environment for exploring alternative family planning methods. This shift could lead to increased demand for sperm donation services. Additionally, greater social acceptance of single parenthood could fuel the demand for sperm banks among women choosing to build families without a male partner. On the other hand, strong cultural traditions that emphasize family lineage or blood ties might create resistance to using sperm donation. The concept of using donor sperm could be seen as conflicting with traditional family values. Additionally, Confucian ideals emphasizing filial piety and respect for elders may lead some cultures to prioritize natural conception and continuity of the family line, potentially hindering the acceptance of sperm donation. Finally, certain religious beliefs within the Asia Pacific region might hold reservations about assisted reproductive technologies (ART) in general, including sperm donation. This could pose a barrier to the wider adoption of sperm bank services.

Competitive Landscape

The landscape of the Sperm Bank Market is a dynamic mix of established players, emerging fertility clinics, and innovative technology providers. Each entity caters to the diverse needs of individuals and couples seeking assisted reproductive technologies.

Some of the prominent players operating in the Sperm Bank Market include:

California Cryobank, Fairfax Cryobank Inc., Androcryos, Cryos International ApS, The London Sperm Bank, Indian Spertech, European Sperm Bank, XYTEX, ReproTech LLC, New England Cryogenic Center, NORDIC CRYOBANK GROUP, INC

Latest Developments

In May 2022, Legacy, a digital fertility clinic for people with sperm, raised a USD 25M Series B funding round led by Bain Capital Ventures. With this funding, Legacy plans to expand its services and launch Legacy Labs for same-day, at-home service.

In March 2022, Ro acquired Dadi, a fertility company. As part of the acquisition, Ro launched the Ro Sperm Kit, an updated offering powered by Dadi's technology.

In July 2021, India IVF Clinic launched a DIY semen testing kit in Delhi NCR.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SPERM BANK MARKET

  • 1.1 Introduction of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL SPERM BANK MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL SPERM BANK MARKET, BY SERVICES

  • 5.1 Overview
  • 5.2 Sperm Storage
  • 5.3 Genetic Consultation
  • 5.4 Semen Analysis

5 GLOBAL SPERM BANK MARKET, BY DONOR

  • 5.1 Overview
  • 5.2 Known Donor
  • 5.3 Anonymous Donor

7 GLOBAL SPERM BANK MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL SPERM BANK MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 California Cryobank
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Fairfax Cryobank, Inc.
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Androcryos
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Cryos International ApS
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.4 Cryos International ApS
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 CRYOBANK GROUP, INC
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Indian Spertech
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 European Sperm Bank
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 ReproTech LLC
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 XYTEX
    • 9.4.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 New England Cryogenic Center
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

9 KEY DEVELOPMENTS

  • 9.1 Product Launches/Developments
  • 9.2 Mergers and Acquisitions
  • 9.3 Business Expansions
  • 9.4 Partnerships and Collaborations

10 Appendix

  • 10.1 Related Research